Ocera Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the development and commercialization of proprietary compounds to treat acute and chronic orphan liver disease.
Company profile
Website
CEO
Linda S. Grais
Employees
Incorporated
Location
Fiscal year end
Former names
Renovia Inc
SEC CIK
IRS number
470948423